Chandra Daya Investasi Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Chandra Daya Investasi Tbk. trades at Rp705 (market cap 91.75T, 83.71M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume). The key difference: Chandra Daya Investasi Tbk. is far larger — about 195× Prodia Diagnostic Line Tbk's market cap, and Chandra Daya Investasi Tbk. is more actively traded (83.71M versus 28.43M). Which is the better fit depends on your goals.
| CDIA | PRDL | |
|---|---|---|
Market Cap | 91.75T | 470.58B |
Volume | 83.71M | 28.43M |
Lot | 837.13K | 284.34K |
Turnover | 59.63B | 7.8B |
Average Price | 712.33 | 274.19 |
Value | 59.63B | 7.8B |
Indicative Equilibrium Price | 705 | 270 |
Indicative Equilibrium Volume | 8.08K | 2.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Chandra Daya Investasi Tbk. the (Company) was established based on Notarial Deed No. 26 dated February 8, 2023, of Jose Dirma Satria, S.H., M.Kn., Notary in Jakarta. The Company started its commercial operations in 2023. The Company is a subsidiary of PT Chandra Asri Pacific Tbk and belongs to a group of companies owned by PT Barito Pacific Tbk (Barito Pacific Group). Mr. Pajogo Pangestu is the ultimate beneficial owner of the Company.
Read more on CDIA →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →